Baseline characteristics of human immunodeficiency virus-hepatitis C virus (HIV-HCV) coinfected patients
| Mean (SD) age (y) | 40.2 (7) |
|---|---|
| Male | 17 (81%) |
| Risk factor for HIV-HCV infections | |
| Intravenous drug use | 17 (81%) |
| Transfusion | 3 (14.3%) |
| Antiretroviral therapy | |
| Zidovudine | 8 (38%) |
| Stavudine | 13 (62%) |
| HIV-1 protease inhibitor | 12 (57%) |
| Duration of antiretroviral therapy (months) | |
| Median (95% CI) | 8.3 (6.0–10.5) |
| Range | 3–22 |
| Cirrhosis (No (%)) | 11 (52.4%) |